Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Szigeti

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
Orvosi Hetilap|February 9, 1975
[Mucolipidosis type II (I-cell disease)]R Szigeti, E Konyár, A Görgényi, et al.
Molecular Immunology|November 1, 1988
Immunomodulatory effect of synthetic peptides corresponding to sequences within the CH2 and CH3 domain of human IgG1G Sàrmay, K Reguly, R Szigeti, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 21, 2007
Premenstrual exacerbation in calcium ATPase disorders of the skinR Szigeti, S-C Chao, O Szász, et al.
Immunology Letters|January 1, 1985
Leukocyte migration inhibitory factor production by activated lymphocytes representing immunological memory or virus-receptor interaction: response of T cell subsets to Epstein-Barr virus nuclear antigen, response of B cells to UV inactivated Epstein-Barr virusR Szigeti, M G Masucci, G Masucci, et al.
Clinical Immunology and Immunopathology|January 1, 1982
Effect of different Epstein-Barr virus-determined antigens (EBNA, EA, and VCA) on the leukocyte migration of healthy donors and patients with infectious mononucleosis and certain immunodeficienciesR Szigeti, M G Masucci, W Henle, et al.
International Journal of Cancer|October 15, 1987
Cellular and humoral immune responses to synthetic peptides deduced from the amino-acid sequences of Epstein-Barr virus-encoded proteins in EBV-transformed cellsJ Dillner, R Szigeti, W Henle, et al.
Clinical Genetics|August 23, 2006
CYLD mutations underlie Brooke-Spiegler, familial cylindromatosis, and multiple familial trichoepithelioma syndromesA L Young, R Kellermayer, R Szigeti, et al.
Cancer Research|May 1, 1983
Epstein-Barr virus-specific leukocyte migration inhibition reaction with tumor biopsy extracts: correlation with the presence of viral DNAR Szigeti, A K Saemundsen, A C Synnerholm, et al.
Journal of Immunological Methods|January 1, 1981
Use of cryopreserved lymphocytes for the indirect leukocyte migration inhibition assayR Szigeti, D Stevens, I Ernberg, et al.
Orvosi Hetilap|May 16, 1982
[Leukocyte migration inhibition elicited by Epstein-Barr virus antigen. Reaction potential in infectious mononucleosis as well as in states of immune deficiency and immunosuppression]R Szigeti, E Klein, M G Masucci, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
Orvosi Hetilap|February 9, 1975
[Mucolipidosis type II (I-cell disease)]R Szigeti, E Konyár, A Görgényi, et al.
Molecular Immunology|November 1, 1988
Immunomodulatory effect of synthetic peptides corresponding to sequences within the CH2 and CH3 domain of human IgG1G Sàrmay, K Reguly, R Szigeti, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 21, 2007
Premenstrual exacerbation in calcium ATPase disorders of the skinR Szigeti, S-C Chao, O Szász, et al.
Immunology Letters|January 1, 1985
Leukocyte migration inhibitory factor production by activated lymphocytes representing immunological memory or virus-receptor interaction: response of T cell subsets to Epstein-Barr virus nuclear antigen, response of B cells to UV inactivated Epstein-Barr virusR Szigeti, M G Masucci, G Masucci, et al.
Clinical Immunology and Immunopathology|January 1, 1982
Effect of different Epstein-Barr virus-determined antigens (EBNA, EA, and VCA) on the leukocyte migration of healthy donors and patients with infectious mononucleosis and certain immunodeficienciesR Szigeti, M G Masucci, W Henle, et al.
International Journal of Cancer|October 15, 1987
Cellular and humoral immune responses to synthetic peptides deduced from the amino-acid sequences of Epstein-Barr virus-encoded proteins in EBV-transformed cellsJ Dillner, R Szigeti, W Henle, et al.
Clinical Genetics|August 23, 2006
CYLD mutations underlie Brooke-Spiegler, familial cylindromatosis, and multiple familial trichoepithelioma syndromesA L Young, R Kellermayer, R Szigeti, et al.
Cancer Research|May 1, 1983
Epstein-Barr virus-specific leukocyte migration inhibition reaction with tumor biopsy extracts: correlation with the presence of viral DNAR Szigeti, A K Saemundsen, A C Synnerholm, et al.
Journal of Immunological Methods|January 1, 1981
Use of cryopreserved lymphocytes for the indirect leukocyte migration inhibition assayR Szigeti, D Stevens, I Ernberg, et al.
Orvosi Hetilap|May 16, 1982
[Leukocyte migration inhibition elicited by Epstein-Barr virus antigen. Reaction potential in infectious mononucleosis as well as in states of immune deficiency and immunosuppression]R Szigeti, E Klein, M G Masucci, et al.
Pageof 8